{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:40:10Z","timestamp":1745610010034,"version":"3.40.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03616-x","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T07:14:04Z","timestamp":1745565244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tuberculosis in children and adolescents using biological agents: a nationwide cohort study from Turkey"],"prefix":"10.1186","volume":"25","author":[{"given":"Tugba","family":"Sismanlar Eyuboglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Tana","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Medeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Ata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Mahir","family":"Ulgu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suayip","family":"Birinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"3616_CR1","doi-asserted-by":"publisher","first-page":"105120","DOI":"10.1016\/j.phrs.2020.105120","volume":"161","author":"F Penagini","year":"2020","unstructured":"Penagini F, Cococcioni L, Pozzi E, Dilillo D, Rendo G, Mantegazza C, Zuccotti GV. Biological therapy in pediatric age. Pharmacol Res. 2020;161:105120.","journal-title":"Pharmacol Res"},{"issue":"2","key":"3616_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00431-010-1238-z","volume":"170","author":"L Breda","year":"2011","unstructured":"Breda L, Del Torto M, De Sanctis S, Chiarelli F. Biologics in children\u2019s autoimmune disorders: efficacy and safety. Eur J Pediatr. 2011;170(2):157\u201367.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3616_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/ar2594","volume":"11","author":"JD Isaacs","year":"2009","unstructured":"Isaacs JD. Antibody engineering to develop new antirheumatic therapies. Arthritis Res Ther. 2009;11(3):225.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3616_CR4","doi-asserted-by":"publisher","first-page":"e20190361","DOI":"10.1590\/1806-3713\/e20190361","volume":"45","author":"FS Aguiar","year":"2019","unstructured":"Aguiar FS, Mello FCQ. Latent tuberculosis and the use of Immunomodulatory agents. J Bras Pneumol. 2019;45(6):e20190361.","journal-title":"J Bras Pneumol"},{"key":"3616_CR5","doi-asserted-by":"publisher","first-page":"705669","DOI":"10.3389\/fphar.2021.705669","volume":"12","author":"S Man","year":"2021","unstructured":"Man S, Hu L, Ji X, Wang Y, Ma Y, Wang L, Zhu J, Huang F. Risk of malignancy and tuberculosis of biological and targeted drug in patients with spondyloarthritis: systematic review and Meta-analysis of randomized controlled trials. Front Pharmacol. 2021;12:705669.","journal-title":"Front Pharmacol"},{"key":"3616_CR6","doi-asserted-by":"publisher","first-page":"e2022084","DOI":"10.1590\/1984-0462\/2024\/42\/2022084","volume":"42","author":"LM Lima","year":"2023","unstructured":"Lima LM, Aurilio RB, Fonseca AR, Parente AAAI, Sant\u2019Anna MFBP, Sant\u2019Anna CC. Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review. Rev Paul Pediatr. 2023;42:e2022084.","journal-title":"Rev Paul Pediatr"},{"issue":"4","key":"3616_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/CM9.0000000000001948","volume":"135","author":"X Ji","year":"2022","unstructured":"Ji X, Hu L, Wang Y, Man S, Liu X, Song C, Zhang J, Zhu J, Zhang J, Huang F. Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs: meta-analysis of randomized clinical trials. Chin Med J (Engl). 2022;135(4):409\u201315.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"3616_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.46497\/ArchRheumatol.2023.9900","volume":"38","author":"N Bayram","year":"2023","unstructured":"Bayram N, Altu\u011f G\u00fccenmez \u00d6, Makay B, et al. Risk of tuberculosis in children with rheumatologic diseases treated with biological agents: A cross-sectional cohort study. Arch Rheumatol. 2023;38(4):549\u201355.","journal-title":"Arch Rheumatol"},{"key":"3616_CR9","unstructured":"Qureshi O, Dua A. COX Inhibitors. [Updated 2024 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549795\/"},{"key":"3616_CR10","unstructured":"Tuberculosis surveillance and monitoring in Europe 2023. 2021 data. Available at: https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289058810. Accessed October, 2024."},{"issue":"2","key":"3616_CR11","first-page":"68","volume":"25","author":"A Naci Emecen","year":"2024","unstructured":"Naci Emecen A, K\u0131ran P, \u00c7a\u011flayan D. Influential factors of tuberculosis notification rates in Turkey: A Provincial-Level Spatial analysis. Thorac Res Pract. 2024;25(2):68\u201374.","journal-title":"Thorac Res Pract"},{"key":"3616_CR12","unstructured":"Turkiye\u2019de Verem Sava\u015f\u0131 Raporu. 2021. (Tuberculosis Report of Turkiye 2021). Republic of Turkey Ministry of Health. Available from: chrome- http:\/\/extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/tuberkuloz-db\/Dokumanlar\/Raporlar\/Turkiyede_Verem_Savasi_2021_Raporu.pdf, Accessed March, 2025."},{"key":"3616_CR13","doi-asserted-by":"crossref","unstructured":"Dobler CC. Biologic Agents and Tuberculosis. Microbiol Spectr. 2016;4(6).","DOI":"10.1128\/microbiolspec.TNMI7-0026-2016"},{"issue":"1","key":"3616_CR14","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.1038\/s41598-017-06899-1","volume":"7","author":"EH Lee","year":"2017","unstructured":"Lee EH, Kang YA, Leem AY, Park MS, Kim YS, Kim SK, Chang J, Kim SY. Active tuberculosis incidence and characteristics in patients treated with tumor necrosis factor antagonists according to latent tuberculosis infection. Sci Rep. 2017;7(1):6473.","journal-title":"Sci Rep"},{"issue":"10","key":"3616_CR15","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/cid\/ciz1138","volume":"71","author":"A Noguera-Julian","year":"2020","unstructured":"Noguera-Julian A, Calzada-Hern\u00e1ndez J, Brinkmann F, Basu Roy R, Bilogortseva O, Buettcher M, Carvalho I, Chechenyeva V, Falc\u00f3n L, Goetzinger F, Guerrero-Laleona C, et al. Tuberculosis disease in children and adolescents on therapy with antitumor necrosis Factor-\u0251 agents: A collaborative, multicenter paediatric tuberculosis network European trials group (ptbnet) study. Clin Infect Dis. 2020;71(10):2561\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3616_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2352-4642(19)30337-2","volume":"4","author":"KJ Snow","year":"2020","unstructured":"Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, Dodd PJ, Houben RM, Denholm JT, Sawyer SM, Kranzer K. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020;4(1):68\u201379.","journal-title":"Lancet Child Adolesc Health"},{"key":"3616_CR17","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.3389\/fimmu.2018.02946","volume":"9","author":"JA Seddon","year":"2018","unstructured":"Seddon JA, Chiang SS, Esmail H, Coussens AK. The Wonder years: what can primary school children teach Us about immunity to Mycobacterium tuberculosis? Front Immunol. 2018;9:2946.","journal-title":"Front Immunol"},{"issue":"3","key":"3616_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11515-015-1358-y","volume":"10","author":"D Yang","year":"2015","unstructured":"Yang D, Kong Y. The bacterial and host factors associated with extrapulmonary dissemination of Mycobacterium tuberculosis. Front Biol (Beijing). 2015;10(3):252\u201361.","journal-title":"Front Biol (Beijing)"},{"issue":"5","key":"3616_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/sj.gene.6364405","volume":"8","author":"NT Thuong","year":"2007","unstructured":"Thuong NT, Hawn TR, Thwaites GE, Chau TT, Lan NT, Quy HT, Hieu NT, Aderem A, Hien TT, Farrar JJ, Dunstan SJ. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun. 2007;8(5):422\u20138.","journal-title":"Genes Immun"},{"issue":"15","key":"3616_CR20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis is associated with Infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345(15):1098\u2013104.","journal-title":"N Engl J Med"},{"issue":"2","key":"3616_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.27271","volume":"62","author":"PL Lin","year":"2010","unstructured":"Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, Grieser H, Chiosea I, Voitenek NN, Capuano SV, Klein E, Flynn JL. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 2010;62(2):340\u201350.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3616_CR22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/605559","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the united States, 1993\u20132006. Clin Infect Dis. 2009;49(9):1350\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3616_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cid\/cir788","volume":"54","author":"ES Click","year":"2012","unstructured":"Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis. 2012;54(2):211\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3616_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41426-018-0106-1","volume":"7","author":"X Qian","year":"2018","unstructured":"Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis. Emerg Microbes Infect. 2018;7(1):102.","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"3616_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.21101\/cejph.a7499","volume":"30","author":"K Dole\u017ealov\u00e1","year":"2022","unstructured":"Dole\u017ealov\u00e1 K, Kika V, G\u00f6pfertov\u00e1 D, Wallenfels J. Trends in the incidence of extrapulmonary tuberculosis in children in the Czech Republic in the past 35 years. Cent Eur J Public Health. 2022;30(4):207\u201312.","journal-title":"Cent Eur J Public Health"},{"issue":"1","key":"3616_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1080\/22221751.2022.2054367","volume":"11","author":"P Chu","year":"2022","unstructured":"Chu P, Chang Y, Zhang X, Han S, Jin Y, Yu Y, Yang Y, Feng G, Wang X, Shen Y, Ni X, Guo Y, Lu J. Futang research center of and pediatric development (FRCPD). Epidemiology of extrapulmonary tuberculosis among pediatric inpatients in Mainland China: a descriptive, multicenter study. Emerg Microbes Infect. 2022;11(1):1090\u2013102.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"3616_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12890-017-0425-3","volume":"17","author":"CW Wu","year":"2017","unstructured":"Wu CW, Wu JY, Lee MG, Lai CC, Wu IL, Tsai YW, Chang SS, Lee CC. Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study. BMC Pulm Med. 2017;17(1):82.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"3616_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","volume":"208","author":"C Vilaplana","year":"2013","unstructured":"Vilaplana C, Marzo E, Tapia G, Diaz J, Garcia V, Cardona PJ. Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J Infect Dis. 2013;208(2):199\u2013202.","journal-title":"J Infect Dis"},{"key":"3616_CR29","doi-asserted-by":"publisher","first-page":"970408","DOI":"10.3389\/fmed.2022.970408","volume":"9","author":"JM Cubillos-Angulo","year":"2022","unstructured":"Cubillos-Angulo JM, Nogueira BMF, Arriaga MB, Barreto-Duarte B, Ara\u00fajo-Pereira M, Fernandes CD, Vinhaes CL, Villalva-Serra K, Nunes VM, Miguez-Pinto JP, Amaral EP, Andrade BB. Host-directed therapies in pulmonary tuberculosis: updates on anti-inflammatory drugs. Front Med (Lausanne). 2022;9:970408.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"3616_CR30","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/infdis\/jiad390","volume":"229","author":"KG Nore","year":"2024","unstructured":"Nore KG, Louet C, Bugge M, Gidon A, J\u00f8rgensen MJ, Jenum S, Dyrhol-Riise AM, Tonby K, Flo TH. The cyclooxygenase 2 inhibitor Etoricoxib as adjunctive therapy in tuberculosis impairs macrophage control of mycobacterial growth. J Infect Dis. 2024;229(3):888\u201397.","journal-title":"J Infect Dis"},{"key":"3616_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s42003-019-0530-3","volume":"2","author":"R Mortensen","year":"2019","unstructured":"Mortensen R, Clemmensen HS, Woodworth JS, Therkelsen ML, Mustafa T, Tonby K, Jenum S, Agger EM, Dyrhol-Riise AM, Andersen P. Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice. Commun Biol. 2019;2:288.","journal-title":"Commun Biol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03616-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:02:55Z","timestamp":1745607775000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03616-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3616"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03616-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the Declaration of Helsinki and received approval from the Turkish Ministry of Health with a waiver for informed consent for retrospective data analysis and the health information privacy law (Date:11\/27\/2019, Number:95741342-020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}